Jiuhong Zha Selected Research

paritaprevir

1/2020	Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3-11 Years with Hepatitis C Genotype 1a.
2/2019	Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials.
2/2019	Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease.
2/2019	Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese Patients.
11/2018	Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4.
11/2018	Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Hepatitis C Virus-Infected Cirrhotic and Non-cirrhotic Patients: Analyses Across Nine Phase III Studies.
1/2018	Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.
10/2017	Clinical Pharmacokinetics of Dasabuvir.
1/2017	Pharmacokinetic Evaluation of Darunavir Administered Once or Twice Daily in Combination with Ritonavir or the Three-Direct-Acting Antiviral Regimen of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults Coinfected with Hepatitis C and Human Immunodeficiency Viruses.
1/2016	Exposure-Response Relationship for Ombitasvir and Paritaprevir/Ritonavir in Hepatitis C Virus Subgenotype 1b-Infected Japanese Patients in the Phase 3 Randomized GIFT-I Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiuhong Zha Research Topics

Disease

11	Infections 04/2022 - 07/2015
5	Chronic Hepatitis C 01/2020 - 07/2015
2	Thrombocytopenia (Thrombopenia) 04/2022 - 01/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 01/2022
2	Hepatitis C 01/2020 - 01/2017
2	Fibrosis (Cirrhosis) 01/2020 - 02/2019
2	Chronic Renal Insufficiency 02/2019 - 02/2019
2	Cystic Fibrosis (Mucoviscidosis) 03/2014 - 11/2010
1	Neutropenia 04/2022
1	Constipation 01/2022
1	Febrile Neutropenia 01/2022
1	Body Weight (Weight, Body) 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2019
1	Kidney Diseases (Kidney Disease) 02/2019
1	Anemia 01/2018
1	Hemolytic Anemia 01/2018
1	Viremia 01/2017
1	Coinfection 01/2017
1	Edema (Dropsy) 01/2016
1	Virus Diseases (Viral Diseases) 11/2015
1	Exanthema (Rash) 11/2010

Drug/Important Bio-Agent (IBA)

13	Ritonavir (Norvir)FDA Link 01/2020 - 07/2015
13	paritaprevirIBA 01/2020 - 07/2015
13	ombitasvirIBA 01/2020 - 07/2015
9	dasabuvirIBA 01/2020 - 07/2015
8	Antiviral Agents (Antivirals)IBA 01/2020 - 07/2015
6	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 01/2017
3	Pharmaceutical PreparationsIBA 02/2019 - 01/2016
2	venetoclaxIBA 04/2022 - 01/2022
2	ivacaftorIBA 03/2014 - 11/2010
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	TabletsIBA 01/2020
1	glecaprevir and pibrentasvirIBA 01/2020
1	SolutionsIBA 01/2020
1	InterferonsIBA 01/2018
1	Inosine TriphosphataseIBA 01/2018
1	NucleosidesIBA 10/2017
1	Darunavir (Prezista)FDA Link 01/2017
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2016
1	BilirubinIBA 01/2016
1	ChloridesIBA 03/2014
1	neodymium pyrocatechin disulfonate (NPD)IBA 03/2014
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2010

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2022 - 01/2022
1	Therapeutics 11/2018